Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MIR3945 host gene (MIR3945HG) is a long non-coding RNA (lncRNA) gene in Homo sapiens, found to be differentially expressed in various immune and infectious contexts. Its expression is upregulated in active pulmonary tuberculosis and it has been proposed as a diagnostic biomarker for tuberculosis. In system-level host response studies, expression changes of MIR3945HG have also been associated with differences in the immune response to Mycobacterium tuberculosis infections, particularly in macrophages, and have been reported in transcriptomic analyses of HIV persistence, though the functional mechanism of the gene is not well-characterized. MIR3945HG is not a classical therapeutic target (such as a receptor or enzyme), but may serve as a disease biomarker, particularly in infectious disease contexts[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MIR3945 host gene (MIR3945HG).